Skip to Main Content


Skip Nav Destination

Abstract OT3-02-02: PATHWAY: Asian, multicenter, phase 3 trial of tamoxifen with or without palbociclib ± goserelin in women with hormone receptor-positive, HER2-negative advanced or metastatic breast cancer

Cancer Res (2019) 79 (4_Supplement): OT3-02-02.
This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.
  • Muhammad Jameel Mughal
  • Kinjal Bhadresha
  • Hang Fai Kwok
Seminars in Cancer Biology (2023) 88: 106.
Close Modal

or Create an Account

Close Modal
Close Modal